USOD’s Medical Outreach Program provides information about Down syndrome to families as well as pediatricians, obstetricians, nurses, social workers, genetic counselors, midwives and other healthcare providers seeking information. The primary goal of this program is to ensure that all parents and expectant parents with a possible or actual diagnosis of Down syndrome are given factual non-biased information with sensitivity and support, including information about USOD.
The USOD welcomes the opportunity to provide the medical community with accurate and relevant information about Down Syndrome. We can provide speakers at conferences, meetings and grand rounds presentations upon request. We want to help the medical community deliver the best care possible for their patients with Down Syndrome and their families.
- The Implications of Obstructive Sleep Apnea in People with Down Syndrome, presented by Dr. Joshua Greene – view video HERE
- Celiac Disease and Down Syndrome
- Dr. Roxanne Sukol, guest speaker at USOD Medical Night, 4/19/16.
View her TED Talk.
- Mammography Guidelines for Women with Down Syndrome
- Alzheimer’s Disease in People with Down Syndrome
- Moyamoya Disease
- Dental Care Guidelines for Caregivers of Patients with Down Syndrome
Information for Medical Professionals
All research posted through the Up Side of Downs has undergone rigorous acceptance standards from their sponsoring institutions including but not limited to review by their IRB committee. Under FDA regulations, an IRB is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. In accordance with FDA regulations, an IRB has the authority to approve, require modifications In (to secure approval) or disapprove research.
- Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Adolescents and Young Adults with Down Syndrome: A team of medical doctors and psychologists at the Case Western Reserve University, University Hospitals and the Cleveland Clinic is investigating the effects of memantine on individuals with Down syndrome between the ages of 15 and 32. To learn more about the study and how to participate, click Memantine Study flyer.
- Family Factors and the Quality of Life in Children with Down Syndrome: The purpose of this study is to learn about how parents view family functioning and quality of life of children with Down syndrome. Learn more here.
- Neurodegeneration in Aging Down Syndrome: The University of Pittsburgh Medical Center is seeking adults at least 25 years of age with Down syndrome to participate in this research study. The study involves both cognitive testing and scans of the brain via MRI and PET. Learn more here-NiAD Research Study
- HELP-DS: Healthy Sleep for Children with Down Syndrome (HELP-DS) is a research study to observe breathing, sleep and behavior in children with Ds before and after treatment for Sleep Disordered Breathing (SDB). Children with Down syndrome age 3-12.9 years who have not had their tonsils and and adenoid removed are eligible to participate. The study is being conducted by researchers at University Hospitals and Rainbow Babies and Children’s Hospital in Cleveland. Learn more here.